Transcriptome classification reveals molecular subtypes in psoriasis
- PMID: 22971201
- PMCID: PMC3481433
- DOI: 10.1186/1471-2164-13-472
Transcriptome classification reveals molecular subtypes in psoriasis
Abstract
Background: Psoriasis is an immune-mediated disease characterised by chronically elevated pro-inflammatory cytokine levels, leading to aberrant keratinocyte proliferation and differentiation. Although certain clinical phenotypes, such as plaque psoriasis, are well defined, it is currently unclear whether there are molecular subtypes that might impact on prognosis or treatment outcomes.
Results: We present a pipeline for patient stratification through a comprehensive analysis of gene expression in paired lesional and non-lesional psoriatic tissue samples, compared with controls, to establish differences in RNA expression patterns across all tissue types. Ensembles of decision tree predictors were employed to cluster psoriatic samples on the basis of gene expression patterns and reveal gene expression signatures that best discriminate molecular disease subtypes. This multi-stage procedure was applied to several published psoriasis studies and a comparison of gene expression patterns across datasets was performed.
Conclusion: Overall, classification of psoriasis gene expression patterns revealed distinct molecular sub-groups within the clinical phenotype of plaque psoriasis. Enrichment for TGFb and ErbB signaling pathways, noted in one of the two psoriasis subgroups, suggested that this group may be more amenable to therapies targeting these pathways. Our study highlights the potential biological relevance of using ensemble decision tree predictors to determine molecular disease subtypes, in what may initially appear to be a homogenous clinical group. The R code used in this paper is available upon request.
Figures







Similar articles
-
Association of the Psoriatic Microenvironment With Treatment Response.JAMA Dermatol. 2020 Oct 1;156(10):1057-1065. doi: 10.1001/jamadermatol.2020.2118. JAMA Dermatol. 2020. PMID: 32876657 Free PMC article.
-
Exploratory multi-omics analysis reveals host-microbe interactions associated with disease severity in psoriatic skin.EBioMedicine. 2024 Jul;105:105222. doi: 10.1016/j.ebiom.2024.105222. Epub 2024 Jun 25. EBioMedicine. 2024. PMID: 38924840 Free PMC article.
-
Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications.PLoS One. 2015 Jul 15;10(7):e0132454. doi: 10.1371/journal.pone.0132454. eCollection 2015. PLoS One. 2015. PMID: 26176783 Free PMC article.
-
Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes.J Cell Mol Med. 2020 Dec;24(23):13554-13563. doi: 10.1111/jcmm.15742. Epub 2020 Oct 31. J Cell Mol Med. 2020. PMID: 33128843 Free PMC article. Review.
-
Review-Current Concepts in Inflammatory Skin Diseases Evolved by Transcriptome Analysis: In-Depth Analysis of Atopic Dermatitis and Psoriasis.Int J Mol Sci. 2020 Jan 21;21(3):699. doi: 10.3390/ijms21030699. Int J Mol Sci. 2020. PMID: 31973112 Free PMC article. Review.
Cited by
-
Signaling pathways and targeted therapies for psoriasis.Signal Transduct Target Ther. 2023 Nov 27;8(1):437. doi: 10.1038/s41392-023-01655-6. Signal Transduct Target Ther. 2023. PMID: 38008779 Free PMC article. Review.
-
Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.J Invest Dermatol. 2023 Aug;143(8):1412-1422. doi: 10.1016/j.jid.2023.04.005. Epub 2023 Jun 20. J Invest Dermatol. 2023. PMID: 37341663 Free PMC article. Review.
-
Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials.Dermatol Ther (Heidelb). 2025 Jun;15(6):1441-1453. doi: 10.1007/s13555-025-01418-x. Epub 2025 Apr 24. Dermatol Ther (Heidelb). 2025. PMID: 40274711 Free PMC article.
-
Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential.Int J Mol Sci. 2022 Feb 1;23(3):1693. doi: 10.3390/ijms23031693. Int J Mol Sci. 2022. PMID: 35163615 Free PMC article. Review.
-
Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation.PLoS One. 2013 Nov 15;8(11):e79253. doi: 10.1371/journal.pone.0079253. eCollection 2013. PLoS One. 2013. PMID: 24260178 Free PMC article. Clinical Trial.
References
-
- Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. - PubMed
-
- Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197–1204. - PubMed
-
- Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–873. - PubMed
-
- Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD. et al.Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet. 2007;122(2):201–206. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous